市場調査レポート
商品コード
1296741

臨床試験イメージング市場の2028年までの予測- モダリティ別、提供サービス別(運用イメージングサービス、イメージングソフトウェア、分析サービスの読み取り、試験デザイン・コンサルティングサービス、その他)、エンドユーザー別の世界分析

Clinical Trial Imaging Market Forecast to 2028 - Global Analysis By Modality, Offering (Operational Imaging Services, Imaging Software, Read Analysis Services, Trial Design and Consulting Services, and Others), and End User

出版日: | 発行: The Insight Partners | ページ情報: 英文 186 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.95円
臨床試験イメージング市場の2028年までの予測- モダリティ別、提供サービス別(運用イメージングサービス、イメージングソフトウェア、分析サービスの読み取り、試験デザイン・コンサルティングサービス、その他)、エンドユーザー別の世界分析
出版日: 2023年05月23日
発行: The Insight Partners
ページ情報: 英文 186 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

臨床試験イメージング市場規模は、2022年の16億1,000万米ドルから2028年には24億8,000万米ドルに達すると予測され、2023年から2028年までのCAGRは7.6%で成長すると推定されます。

医療画像サービスを提供するCRO数の急増が市場成長を後押し

臨床研究機関(CRO)は、高品質な施設と深い専門知識を駆使して提供するサービスを通じて、臨床試験の成功を支援しています。CROは効率的で費用対効果の高い運営を行い、治験依頼者に利益をもたらすため、臨床試験業界の屋台骨となっています。例えば、CROが臨床試験を実施し完了するまでに要する時間は、社内活動よりも平均して30%短いです。

CROの数が増加し競争が激しくなる中、一部のCROはイメージングに特化したサービスを提供し、イメージングCRO(iCRO)として台頭してきています。Keosys Medical ImagingやMedica Group PLCがiCROの例です。臨床試験の総数は2010年以降倍増しており、これらの臨床試験における画像診断の利用は約500%増加しています。KEOSYS MEDICAL IMAGING社のレポートによると、iCROは予算の7.5~10%を画像診断に割り当てており、画像取得から判読に至るプロセスの全段階を管理するワークフローの最適化に役立っています。これらのCROは、画像取得のための施設認定、標準化された画像の取得、読影デザインと基準の決定などの分野で重要な知識を提供し、臨床試験イメージング市場全体の成長に貢献しています。

市場機会

インシリコイメージング臨床試験は今後数年で市場機会をもたらす

SPIEによる2023年の報告書によると、臨床試験は高価で長期間かかるため、規制当局の評価が遅れ、患者が新規で高品質な医薬品を入手するのに大きく影響します。インシリコイメージングは、誤差が少ないため臨床試験よりも負担が少なく、イメージング技術の安全性と有効性の評価に採用されています。臨床試験におけるインシリコイメージングは、画像システム全体/その構成要素(ソース、対象物、タスク、観察者構成要素など)のコンピュータシミュレーションを支援し、研究、開発、最適化、技術評価、規制評価を支援します。

インシリコイメージング試験は、新しい医療用イメージングシステムの評価に不可欠です。2019年3月には、デジタルマンモグラフィとデジタル乳房トモシンセシスを比較するために、2,986人のインシリコ患者のコンピュータシミュレーションイメージングを用いたVirtual Imaging Clinical Trial for Regulatory Evaluation(VICTRE)が実施されました。インシリコ試験を取り入れることにより病変検出性能が向上し、すべての乳房サイズと病変タイプでトモシンセシスが有利となっています。VICTREの調査結果によると、インシリコ画像試験とコンピュータシミュレーションイメージングツールは、画像診断機器の規制評価において有効なエビデンス源となる可能性が高く、臨床試験イメージング市場の成長に有利な機会を提供します。

中国は2022年にアジア太平洋地域の臨床試験イメージング市場で最大のシェアを占め、予測期間中にCAGR 8.6%を記録すると予想されます。中国市場の成長の主な要因は、確立された医薬品市場、製薬・バイオ医薬品企業による研究開発費の増加、低コストによる臨床試験数の増加、有利な規制政策にあります。中国は世界第2位の医薬品市場です。中国の人口の多さと、様々な伝染病や非伝染病の流行が、中国における製薬会社の成長を後押しする主な要因となっています。

臨床試験イメージング市場の主要企業は、様々な戦略を通じて成長を確保しています。2022年1月、臨床試験のためのソリューションを提供するテクノロジー企業であるClarioと、放射性医薬品製造と陽電子放射断層撮影のXingImagingは、中国で新規治療薬を試験するためのPET画像臨床試験を提供するために提携を拡大しました。

National Institute for Health Research's Clinical Research Network、Centers for Disease Control and Prevention(CDC)、South Australian Health and Medical Research Institute、Exploratory Oncology Research &Clinical Trial Center、The Therapeutic Goods Administration(TGA)などは、臨床試験イメージング市場に関する報告書を作成する際に参照した主要な一次情報と二次情報です。

目次

第1章 イントロダクション

第2章 臨床試験イメージング市場-主要な要点

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 臨床試験イメージング市場- 市場情勢

  • PEST分析
    • 北米PEST分析
    • 欧州PEST分析
    • アジア太平洋PEST分析
    • 中東・アフリカPEST分析
    • 中南米PEST分析
  • 専門家の見解

第5章 臨床試験イメージング市場- 主な市場力学

  • 市場促進要因
    • 製薬・バイオテクノロジー業界における臨床試験活動の加速
    • メディカルイメージングサービスを提供するCRO数の急増
  • 市場抑制要因
    • 高額投資と標準化されたインフラ要件
  • 市場機会
    • インシリコイメージング臨床試験
  • 今後の動向
    • AI主導型臨床試験
  • インパクト分析

第6章 臨床試験イメージング市場- 世界分析

  • 臨床試験イメージングの世界市場収益と予測分析
  • 臨床試験イメージングの世界市場:地域別予測・分析
  • 主要企業の市場ポジショニング

第7章 臨床試験イメージング市場の収益と2028年までの予測-モダリティ別

  • 臨床試験イメージング市場のモダリティ別収益シェア(2022年および2028年)
  • トモグラフィ
  • 超音波
  • ポジトロン断層撮影
  • X線
  • 心エコー
  • 磁気共鳴画像法
  • その他

第8章 臨床試験イメージング市場の収益と2028年までの予測- 提供別

  • 臨床試験イメージング市場のオファリング別収益シェア(2022年および2028年)
  • 臨床試験デザインコンサルティングサービス
  • 分析サービスの読み取り
  • 運用イメージングサービス
  • イメージングソフトウェア
  • その他

第9章 臨床試験イメージング市場の収益と2028年までの予測-エンドユーザー別

  • 臨床試験イメージング市場のエンドユーザー別収益シェア(2022年および2028年)
  • 製薬企業およびバイオ医薬品企業
  • 受託研究機関
  • 学術・研究機関
  • その他

第10章 臨床試験イメージング市場-2028年までの収益と予測- 地域別分析

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • その他アジア太平洋地域
  • 中南米
    • ブラジル
    • アルゼンチン
    • その他中南米
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • その他中東とアフリカ

第11章 COVID-19パンデミックが臨床試験イメージング市場に与える影響

  • 北米のCOVID-19パンデミックの評価
  • 欧州
  • アジア太平洋
  • 中南米
  • 中東・アフリカ

第12章 臨床試験イメージング市場- 業界情勢

  • 臨床試験イメージング市場における成長戦略
  • 無機的成長戦略
  • 有機的成長戦略

第13章 企業プロファイル

  • eResearch Technology Inc
  • Calyx Inc
  • ICON PLC
  • VIDA Diagnostics Inc
  • WCG Clinical Inc
  • BioTelemetry Inc
  • Medical Metrics Inc
  • Medpace Holdings Inc
  • Radiant Sage LLC
  • IXICO plc

第14章 付録

図表

List Of Tables

  • Table 1. North America Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 2. North America Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
  • Table 3. North America Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 4. US Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 5. US Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
  • Table 6. US Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. Canada: Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 8. Canada: Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
  • Table 9. Canada: Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 10. Mexico: Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 11. Mexico: Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
  • Table 12. Mexico: Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 13. Europe Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 14. Europe Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
  • Table 15. Europe Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 16. Germany: Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 17. Germany: Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
  • Table 18. Germany: Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 19. UK Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 20. UK Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
  • Table 21. UK Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 22. France: Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 23. France: Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
  • Table 24. France: Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 25. Italy: Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 26. Italy: Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
  • Table 27. Italy: Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 28. Spain: Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 29. Spain: Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
  • Table 30. Spain: Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 31. Rest of Europe: Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 32. Rest of Europe: Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
  • Table 33. Rest of Europe: Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 34. Asia Pacific Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
  • Table 35. Asia Pacific Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
  • Table 36. Asia Pacific Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 37. China Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
  • Table 38. China Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
  • Table 39. China Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 40. Japan Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
  • Table 41. Japan Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
  • Table 42. Japan Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 43. India Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
  • Table 44. India Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
  • Table 45. India Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 46. South Korea Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
  • Table 47. South Korea Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
  • Table 48. South Korea Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 49. Australia Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
  • Table 50. Australia Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
  • Table 51. Australia Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 52. Rest of Asia Pacific Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
  • Table 53. Rest of Asia Pacific Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
  • Table 54. Rest of Asia Pacific Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 55. South and Central America Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
  • Table 56. South and Central America Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
  • Table 57. South and Central America Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 58. Brazil Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
  • Table 59. Brazil Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
  • Table 60. Brazil Clinical Trial Imaging Market, by End Use- Revenue and Forecast to 2028 (US$ Million)
  • Table 61. Argentina Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
  • Table 62. Argentina Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
  • Table 63. Argentina Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 64. Rest of South and Central America Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
  • Table 65. Rest of South and Central America Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
  • Table 66. Rest of South and Central America Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 67. Middle East & Africa Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 68. Middle East & Africa Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
  • Table 69. Middle East & Africa Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 70. South Africa Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 71. South Africa Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
  • Table 72. South Africa Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 73. Saudi Arabia Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 74. Saudi Arabia Clinical Trial Imaging Market, by Product and Services - Revenue and Forecast to 2028 (US$ Million)
  • Table 75. Saudi Arabia Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 76. UAE Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 77. UAE Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
  • Table 78. UAE Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 79. Rest of Middle East & Africa Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 80. Rest of Middle East & Africa Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
  • Table 81. Rest of Middle East & Africa Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 82. Recent Inorganic Growth Strategies in the Clinical Trial Imaging Market
  • Table 83. Recent Organic Growth Strategies in Clinical Trial Imaging Market
  • Table 84. Glossary of Terms

List Of Figures

  • Figure 1. Clinical Trial Imaging Market Segmentation
  • Figure 2. Clinical Trial Imaging Market by Region
  • Figure 3. Global Clinical Trial Imaging Market Overview
  • Figure 4. Tomography Largest Share of Modality Segment in Clinical Trial Imaging Market
  • Figure 5. Asia Pacific Expected to Show Remarkable Growth During Forecast Period
  • Figure 6. Clinical Trial Imaging Market, by Geography (US$ Million)
  • Figure 7. Global Clinical Trial Imaging Market - Leading Country Markets (US$ Million)
  • Figure 8. Global Clinical Trial Imaging Market - Industry Landscape
  • Figure 9. North America: PEST Analysis
  • Figure 10. Europe: PEST Analysis
  • Figure 11. Asia Pacific: PEST Analysis
  • Figure 12. Middle East and Africa: PEST Analysis
  • Figure 13. South and Central America: PEST Analysis
  • Figure 14. Clinical Trial Imaging Market: Impact Analysis of Drivers and Restraints
  • Figure 15. Global Clinical Trial Imaging Market - Revenue Forecast and Analysis - 2021-2028
  • Figure 16. Global Clinical Trial Imaging Market, by Geography - Forecast and Analysis (2022-2028)
  • Figure 17. Market Positioning of Key Players in the Clinical Trial Imaging Market
  • Figure 18. Clinical Trial Imaging Market Revenue Share, by Modality (2022 and 2028)
  • Figure 19. Tomography: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 20. Ultrasound: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 21. PET: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. X-Ray: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 23. Echocardiography: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 24. Magnetic Resonance Imaging: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. Others: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 26. Clinical Trial Imaging Market Revenue Share, by Offering (2022 and 2028)
  • Figure 27. Trial Design Consulting Services: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 28. Read Analysis Services: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 29. Operational Imaging Services: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 30. Imaging Software: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 31. Others: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 32. Clinical Trial Imaging Market Revenue Share, by End User (2022 and 2028)
  • Figure 33. Pharmaceutical and Biopharmaceutical Companies: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 34. Contract Research Organizations: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 35. Academic and Research Institutes: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 36. Others: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 37. North America: Clinical Trial Imaging Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 38. North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 39. North America: Clinical Trial Imaging Market, by Country, 2022 & 2028 (%)
  • Figure 40. US: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 41. Canada: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 42. Mexico: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 43. Europe: Clinical Trial Imaging Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 44. Europe Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 45. Europe: Clinical Trial Imaging Market, by Country, 2022 & 2028 (%)
  • Figure 46. Germany: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 47. UK: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 48. France: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 49. Italy: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 50. Spain: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 51. Rest of Europe: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 52. Asia Pacific: Clinical Trial Imaging Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 53. Asia Pacific Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 54. China Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 55. Japan Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 56. India Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 57. South Korea Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 58. Australia Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 59. Rest of Asia Pacific Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 60. South and Central America: Clinical Trial Imaging Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 61. South and Central America Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 62. Brazil Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 63. Argentina Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 64. Rest of South and Central America Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 65. Middle East & Africa: Clinical Trial Imaging Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 66. Middle East & Africa Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 67. South Africa: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 68. Saudi Arabia: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 69. UAE: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 70. Rest of Middle East & Africa: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 71. Impact of COVID-19 Pandemic on North American Country Markets
  • Figure 72. Impact of COVID-19 Pandemic on European Country Markets
  • Figure 73. Impact of COVID-19 Pandemic In Asia Pacific Country Markets
  • Figure 74. Impact of COVID-19 Pandemic on South and Central America Country Markets
  • Figure 75. Impact of COVID-19 Pandemic on Middle East and Africa Country Markets
  • Figure 76. Growth Strategies in Clinical Trial Imaging Market
目次
Product Code: TIPHE100001201

The clinical trial imaging market size is expected to reach US$ 2.48 billion by 2028 from US$ 1.61 billion in 2022; it is estimated to record a CAGR of 7.6% from 2023 to 2028.

Spur in Number of CROs Offering Medical Imaging Services Bolsters Market Growth

Clinical research organizations (CROs) assist in the successful implementation of clinical trials through the services offered using high-quality facilities and deep subject matter expertise. CROs have become the backbone of the clinical trial industry due to their efficient and cost-effective operations that benefit trial sponsors. For example, on an average, CROs take 30% lesser time than in-house activity to conduct and complete clinical trials.

With the rising number of CROs, leading to high competition, some of these businesses offer specialized imaging services, thus emerging as imaging CROs (iCROs). Keosys Medical Imaging and Medica Group PLC are the examples of iCROs. The total number of clinical trials has doubled since 2010, and the use of imaging modalities in these trials has increased by almost 500%. Per a report by KEOSYS MEDICAL IMAGING company, iCROs allocate 7.5-10% of their budgets for imaging, which helps them optimize their workflow to manage every step of the process, from image acquisition to interpretation. These CROs offer key knowledge insights in areas such as site qualification for imaging, acquisition of standardized images, and determination of read designs and criteria, thereby contributing to the growth of the overall clinical trial imaging market.

Market Opportunity

In-Silico Imaging Clinical Trials to Provide Market Opportunities in Coming Years

According to a 2023 report by the SPIE, clinical trials are expensive and lengthy, which causes delays in regulatory evaluation and significantly affects patients' access to novel and high-quality pharmaceutical products. In-silico imaging is employed in the evaluation of safety and effectiveness of imaging technologies with less burden than clinical trials as they provide minimal errors. In-silico imaging in clinical trials aid in the computer simulation of an entire imaging system/its components (source, object, task, observer components, etc.), which assists in research, development, optimization, technology assessment, and regulatory evaluation.

In-silico imaging trials are vital in evaluating new medical imaging systems. In March 2019, the Virtual Imaging Clinical Trial for Regulatory Evaluation (VICTRE) was conducted using computer-simulated imaging of 2,986 in-silico patients for comparing digital mammography and digital breast tomosynthesis. Incorporating in-silico trials improved lesion detection performance, favoring tomosynthesis for all breast sizes and lesion types. Findings of VICTRE reveal that in-silico imaging trials and computer simulation imaging tools are likely to be viable sources of evidence in the regulatory evaluation of imaging devices, in turn, providing lucrative opportunities for the growth of the clinical trial imaging market.

China held the largest share of the clinical trial imaging market in Asia Pacific in 2022, and it is expected to register a CAGR of 8.6% during the forecast period. The growth of the market in China is primarily attributed to the established pharmaceutical market, increasing R&D expenditures by the pharmaceutical and biopharmaceutical companies, rising number of clinical trials due to lower cost, and favorable regulatory policies. China has the world's second largest pharmaceutical market. The excessive population in China, coupled with the prevalence of various communicable and non-communicable diseases, are the key factors favoring the growth of the pharmaceutical companies in China.

Key players in the clinical trial imaging market secure growth through various strategies. In January 2022, Clario, a technology company that delivers solutions for clinical trials, and XingImaging, a radiopharmaceutical production and positron emission tomography company, expanded their partnership to deliver PET imaging clinical trials for testing novel therapeutics in China.

The National Institute for Health Research's Clinical Research Network, the Centers for Disease Control and Prevention (CDC), South Australian Health and Medical Research Institute, Exploratory Oncology Research & Clinical Trial Center, and Therapeutic Goods Administration (TGA) are a few key primary and secondary sources referred to while preparing the report on the clinical trial imaging market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the clinical trial imaging market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global clinical trial imaging market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Clinical Trial Imaging Market - by Modality
    • 1.3.2 Global Clinical Trial Imaging Market - by Offering
    • 1.3.3 Global Clinical Trial Imaging Market - by End User
    • 1.3.4 Global Clinical Trial Imaging Market - by Geography

2. Clinical Trial Imaging Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Clinical Trial Imaging Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis
    • 4.2.2 Europe PEST Analysis
    • 4.2.3 Asia Pacific PEST Analysis
    • 4.2.4 Middle East and Africa PEST Analysis
    • 4.2.5 South and Central America PEST Analysis
  • 4.3 Expert Opinion

5. Clinical Trial Imaging Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Accelerated Clinical Trial Activities in Pharmaceutical and Biotechnology Industry
    • 5.1.2 Spur in Number of CROs Offering Medical Imaging Services
  • 5.2 Market Restraints
    • 5.2.1 High Investment and Standardized Infrastructure Requirements
  • 5.3 Market Opportunities
    • 5.3.1 In-Silico Imaging Clinical Trials
  • 5.4 Future Trends
    • 5.4.1 AI-Driven Clinical Trials
  • 5.5 Impact Analysis

6. Clinical Trial Imaging Market - Global Analysis

  • 6.1 Global Clinical Trial Imaging Market Revenue Forecast and Analysis
  • 6.2 Global Clinical Trial Imaging Market, by Geography - Forecast and Analysis
  • 6.3 Market Positioning of Key Players

7. Clinical Trial Imaging Market Revenue and Forecast To 2028 - by Modality

  • 7.1 Overview
  • 7.2 Clinical Trial Imaging Market Revenue Share, by Modality (2022 and 2028)
  • 7.3 Tomography
    • 7.3.1 Overview
    • 7.3.2 Tomography: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Ultrasound
    • 7.4.1 Overview
    • 7.4.2 Ultrasound: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.5 Positron Emission Tomography
    • 7.5.1 Overview
    • 7.5.2 PET: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.6 X-Ray
    • 7.6.1 Overview
    • 7.6.2 X-Ray: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.7 Echocardiography
    • 7.7.1 Overview
    • 7.7.2 Echocardiography: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.8 Magnetic Resonance Imaging
    • 7.8.1 Overview
    • 7.8.2 Magnetic Resonance Imaging: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.9 Others
    • 7.9.1 Overview
    • 7.9.2 Others: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)

8. Clinical Trial Imaging Market Revenue and Forecast To 2028 - Offering

  • 8.1 Overview
  • 8.2 Clinical Trial Imaging Market Revenue Share, by Offering (2022 and 2028)
  • 8.3 Trial Design Consulting Services
    • 8.3.1 Overview
    • 8.3.2 Trial Design Consulting Services: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Read Analysis Services
    • 8.4.1 Overview
    • 8.4.2 Read Analysis Services: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.5 Operational Imaging Services
    • 8.5.1 Overview
    • 8.5.2 Operational Imaging Services: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.6 Imaging Software
    • 8.6.1 Overview
    • 8.6.2 Imaging Software: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.7 Others
    • 8.7.1 Overview
    • 8.7.2 Others: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)

9. Clinical Trial Imaging Market Revenue and Forecasts To 2028- by End User

  • 9.1 Overview
  • 9.2 Clinical Trial Imaging Market Revenue Share, by End User (2022 and 2028)
  • 9.3 Pharmaceutical and Biopharmaceutical Companies
    • 9.3.1 Overview
    • 9.3.2 Pharmaceutical and Biopharmaceutical Companies: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Contract Research Organizations
    • 9.4.1 Overview
    • 9.4.2 Contract Research Organizations: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Academic and Research Institutes
    • 9.5.1 Overview
    • 9.5.2 Academic and Research Institutes: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)

10. Clinical Trial Imaging Market - Revenue and Forecast to 2028 - Geographic Analysis

  • 10.1 North America: Clinical Trial Imaging Market
    • 10.1.1 Overview
    • 10.1.2 North America: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
    • 10.1.3 North America: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
    • 10.1.4 North America: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
    • 10.1.5 North America: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
    • 10.1.6 North America: Clinical Trial Imaging Market, by Country, 2022& 2028 (%)
      • 10.1.6.1 US: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.1.1 Overview
        • 10.1.6.1.2 US: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.1.3 US: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.1.6.1.4 US: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.1.6.1.5 US: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
      • 10.1.6.2 Canada: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.2.1 Overview
        • 10.1.6.2.2 Canada: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.2.3 Canada: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.1.6.2.4 Canada: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.1.6.2.5 Canada: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
      • 10.1.6.3 Mexico: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.3.1 Overview
        • 10.1.6.3.2 Mexico: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.3.3 Mexico: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.1.6.3.4 Mexico: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.1.6.3.5 Mexico: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
  • 10.2 Europe: Clinical Trial Imaging Market
    • 10.2.1 Overview
    • 10.2.2 Europe: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
    • 10.2.3 Europe: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
    • 10.2.4 Europe: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
    • 10.2.5 Europe: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
    • 10.2.6 Europe: Clinical Trial Imaging Market, by Country, 2022 & 2028 (%)
      • 10.2.6.1 Germany: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.1.1 Overview
        • 10.2.6.1.2 Germany: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.1.3 Germany: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.2.6.1.4 Germany: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.2.6.1.5 Germany: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
      • 10.2.6.2 UK: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.2.1 Overview
        • 10.2.6.2.2 UK: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.2.3 UK: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.2.6.2.4 UK: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.2.6.2.5 UK: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
      • 10.2.6.3 France: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.3.1 Overview
        • 10.2.6.3.2 France: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.3.3 France: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.2.6.3.4 France: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.2.6.3.5 France: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
      • 10.2.6.4 Italy: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.4.1 Overview
        • 10.2.6.4.2 Italy: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.4.3 Italy: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.2.6.4.4 Italy: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.2.6.4.5 Italy: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
      • 10.2.6.5 Spain: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.5.1 Overview
        • 10.2.6.5.2 Spain: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.5.3 Spain: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.2.6.5.4 Spain: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.2.6.5.5 Spain: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
      • 10.2.6.6 Rest of Europe: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.6.1 Overview
        • 10.2.6.6.2 Rest of Europe: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.6.3 Rest of Europe: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.2.6.6.4 Rest of Europe: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.2.6.6.5 Rest of Europe: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
  • 10.3 Asia Pacific: Clinical Trial Imaging Market
    • 10.3.1 Overview
    • 10.3.2 Asia Pacific: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
    • 10.3.3 Asia Pacific: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
    • 10.3.4 Asia Pacific: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
    • 10.3.5 Asia Pacific: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
    • 10.3.6 Asia Pacific: Clinical Trial Imaging Market, by Country, 2022 & 2028 (%)
      • 10.3.6.1 China: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.1.1 China: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.1.2 China: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.3.6.1.3 China: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.3.6.1.4 China: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
      • 10.3.6.2 Japan: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.2.1 Japan: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.2.2 Japan: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.3.6.2.3 Japan: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.3.6.2.4 Japan: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
      • 10.3.6.3 India: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.3.1 India: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.3.2 India: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.3.6.3.3 India: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.3.6.3.4 India: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
      • 10.3.6.4 South Korea: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.4.1 South Korea: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.4.2 South Korea: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.3.6.4.3 South Korea: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.3.6.4.4 South Korea: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
      • 10.3.6.5 Australia: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.5.1 Australia: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.5.2 Australia: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.3.6.5.3 Australia: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.3.6.5.4 Australia: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
      • 10.3.6.6 Rest of Asia Pacific: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.6.1 Rest of Asia Pacific: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.6.2 Rest of Asia Pacific: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.3.6.6.3 Rest of Asia Pacific: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.3.6.6.4 Rest of Asia Pacific: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
  • 10.4 South and Central America: Clinical Trial Imaging Market
    • 10.4.1 Overview
    • 10.4.2 South and Central America: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
    • 10.4.3 South and Central America: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
    • 10.4.4 South and Central America: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
    • 10.4.5 South and Central America: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
      • 10.4.5.1 Brazil: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.5.1.1 Brazil: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.5.1.2 Brazil: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.4.5.1.3 Brazil: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.4.5.1.4 Brazil: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
      • 10.4.5.2 Argentina: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.5.2.1 Argentina: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.5.2.2 Argentina: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.4.5.2.3 Argentina: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.4.5.2.4 Argentina: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
      • 10.4.5.3 Rest of South and Central America: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.5.3.1 Rest of South and Central America: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.5.3.2 Rest of South and Central America: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.4.5.3.3 Rest of South and Central America: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.4.5.3.4 Rest of South and Central America: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
  • 10.5 Middle East & Africa Clinical Trial Imaging Market
    • 10.5.1 Overview
    • 10.5.2 Middle East & Africa: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
    • 10.5.3 Middle East & Africa: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
    • 10.5.4 Middle East & Africa: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
    • 10.5.5 Middle East & Africa Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
    • 10.5.6 Middle East & Africa: Clinical Trial Imaging Market, by Country, 2022 & 2028 (%)
      • 10.5.6.1 South Africa: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.1.1 Overview
        • 10.5.6.1.2 South Africa: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.1.3 South Africa: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.5.6.1.4 South Africa: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.5.6.1.5 South Africa Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
      • 10.5.6.2 Saudi Arabia: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.2.1 Overview
        • 10.5.6.2.2 Saudi Arabia: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.2.3 Saudi Arabia: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.5.6.2.4 Saudi Arabia: Clinical Trial Imaging Market, by Product and Services, 2020-2028 (US$ Million)
        • 10.5.6.2.5 Saudi Arabia Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
      • 10.5.6.3 UAE: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.3.1 Overview
        • 10.5.6.3.2 UAE: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.3.3 UAE: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.5.6.3.4 UAE: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.5.6.3.5 UAE Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
      • 10.5.6.4 Rest of Middle East & Africa: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.4.1 Overview
        • 10.5.6.4.2 Rest of Middle East & Africa: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.4.3 Rest of Middle East & Africa: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.5.6.4.4 Rest of Middle East & Africa: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.5.6.4.5 Rest of Middle East & Africa Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)

11. Impact Of COVID-19 Pandemic on Clinical Trial Imaging Market

  • 11.1 North America: Assessment of COVID-19 Pandemic
  • 11.2 Europe: Impact Assessment of COVID-19 Pandemic
  • 11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
  • 11.4 South and Central America: Impact Assessment of COVID-19 Pandemic
  • 11.5 Middle East and Africa: Impact Assessment of COVID-19 Pandemic

12. Clinical Trial Imaging Market - Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in Clinical Trial Imaging Market
  • 12.3 Inorganic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Organic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 eResearch Technology Inc
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Calyx Inc
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 ICON PLC
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 VIDA Diagnostics Inc
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 WCG Clinical Inc
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 BioTelemetry Inc
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Medical Metrics Inc
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Medpace Holdings Inc
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Radiant Sage LLC
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 IXICO plc
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms